News in brief: Infection risk calculated with biologics; “Allergy mimic” risks confusion with COVID vax AEs; Physicians urged to avoid stigmatising language in medical records

Infection risk calculated with biologics The risk of serious infections in patients with psoriasis is higher for new users of adalimumab and infliximab than etanercept. A French cohort study of more than 44,000 new users of biologics and targeted therapies also found ustekinumab was associated with a lower risk of serious infections. Serious infections reported ...

Already a member?

Login to keep reading.

© 2021 the limbic